Cash Flow Statement

Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Change in Receivables Change in Receivables Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued Short-Term Debt repayments

Growth Metrics

Others

Odyssey Health (ODYY) Other financing activities (2019 - 2021)

Odyssey Health has reported Other financing activities over the past 3 years, most recently at $129800.0 for Q2 2021.

For Q2 2021, Other financing activities changed N/A year-over-year to $129800.0; the TTM value through Jul 2021 reached $169000.0, changed N/A, while the annual FY2025 figure was $108399.0, 81.24% down from the prior year.
Other financing activities for Q2 2021 was $129800.0 at Odyssey Health, up from $7500.0 in the prior quarter.
Over five years, Other financing activities peaked at $129800.0 in Q2 2021 and troughed at $7500.0 in Q1 2021.
A 3-year average of $54000.0 and a median of $39350.0 in 2019 define the central range for Other financing activities.